Antidote Therapeutics

Developing nicotine-blockers to treat diseases caused by nicotine and addiction

placeGaithersburg, Maryland, United States calendar_todayFounded 2017 groups3 employees language antidotetx.com

Investor mix

2 investors on record.

Investor typeCountShare
Venture capital150%
Other / undisclosed150%
Coming soon